Skip to main content
Top
Published in: BMC Anesthesiology 1/2018

Open Access 01-12-2018 | Research article

Acute heart failure after Orthotopic liver transplantation: a case series from one center

Authors: Sonal Sharma, Kunal Karamchandani, Ryan Wilson, Sean Baskin, Dmitri Bezinover

Published in: BMC Anesthesiology | Issue 1/2018

Login to get access

Abstract

Background

Patients undergoing liver transplantation (LT) can develop acute heart failure (HF) in the postoperative period despite having had a normal cardiac evaluation prior to surgery. End-stage liver disease is often associated with underlying cardiac dysfunction which, while not identified during preoperative testing, manifests itself during or immediately after surgery.

Case presentation

We describe three cases of non-ischemic acute HF developing shortly after LT in patients who had a normal preoperative cardiac evaluation. The challenges associated with both diagnosis and management of acute HF in the setting of a newly implanted graft will be discussed.

Conclusions

Diastolic dysfunction, QTc interval prolongation, and an increase in BNP may be predictive of postoperative HF. Current recommendations for preoperative cardiovascular evaluation of transplant candidates does not include studies examining these risk factors and should be revised. Further investigations are necessary to evaluate these findings.
Literature
1.
go back to reference Schnell F, Donal E, Lorho R, Lavoue S, Gacouin A, Compagnon P, Boudjema K, Mabo P, Le Tulzo Y, Camus C. Severe left-sided heart failure early after liver transplantation. Liver Transpl. 2009;15:1296–305.CrossRefPubMed Schnell F, Donal E, Lorho R, Lavoue S, Gacouin A, Compagnon P, Boudjema K, Mabo P, Le Tulzo Y, Camus C. Severe left-sided heart failure early after liver transplantation. Liver Transpl. 2009;15:1296–305.CrossRefPubMed
2.
go back to reference Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144–65.CrossRefPubMed Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144–65.CrossRefPubMed
3.
go back to reference Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ. Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010;56:539–49.CrossRefPubMed Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ. Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010;56:539–49.CrossRefPubMed
4.
go back to reference Dowsley TF, Bayne DB, Langnas AN, Dumitru I, Windle JR, Porter TR, Raichlin E. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation. 2012;94:646–51.CrossRefPubMed Dowsley TF, Bayne DB, Langnas AN, Dumitru I, Windle JR, Porter TR, Raichlin E. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation. 2012;94:646–51.CrossRefPubMed
5.
go back to reference Eimer MJ, Wright JM, Wang EC, Kulik L, Blei A, Flamm S, Beahan M, Bonow RO, Abecassis M, Gheorghiade M. Frequency and significance of acute heart failure following liver transplantation. Am J Cardiol. 2008;101:242–4.CrossRefPubMed Eimer MJ, Wright JM, Wang EC, Kulik L, Blei A, Flamm S, Beahan M, Bonow RO, Abecassis M, Gheorghiade M. Frequency and significance of acute heart failure following liver transplantation. Am J Cardiol. 2008;101:242–4.CrossRefPubMed
6.
go back to reference Qureshi W, Mittal C, Ahmad U, Alirhayim Z, Hassan S, Qureshi S, Khalid F. Clinical predictors of post-liver transplant new-onset heart failure. Liver Transpl. 2013;19:701–10.CrossRefPubMed Qureshi W, Mittal C, Ahmad U, Alirhayim Z, Hassan S, Qureshi S, Khalid F. Clinical predictors of post-liver transplant new-onset heart failure. Liver Transpl. 2013;19:701–10.CrossRefPubMed
7.
go back to reference Sonny A, Govindarajan SR, Jaber WA, Cywinski JB. Systolic heart failure after liver transplantation: incidence, predictors, and outcome. Clin Transpl. 2018;32:e13199.CrossRef Sonny A, Govindarajan SR, Jaber WA, Cywinski JB. Systolic heart failure after liver transplantation: incidence, predictors, and outcome. Clin Transpl. 2018;32:e13199.CrossRef
8.
go back to reference Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, Piulats J, Rivera F, Rodes J. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology. 1993;18:367–72.PubMed Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, Piulats J, Rivera F, Rodes J. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology. 1993;18:367–72.PubMed
9.
go back to reference Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology. 1996;23:1067–72.CrossRefPubMed Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology. 1996;23:1067–72.CrossRefPubMed
10.
go back to reference Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 1992;103:264–74.CrossRefPubMed Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 1992;103:264–74.CrossRefPubMed
11.
go back to reference Arranz J, Soriano A, Garcia I, Garcia I, Concepcion MT, Navarro J, Arteaga A, Filella X, Bravo P, Barrera M, et al. Effect of proinflammatory cytokines (IL-6, TNF-alpha, IL-1beta) on hemodynamic performance during orthotopic liver transplantation. Transplant Proc. 2003;35:1884–7.CrossRefPubMed Arranz J, Soriano A, Garcia I, Garcia I, Concepcion MT, Navarro J, Arteaga A, Filella X, Bravo P, Barrera M, et al. Effect of proinflammatory cytokines (IL-6, TNF-alpha, IL-1beta) on hemodynamic performance during orthotopic liver transplantation. Transplant Proc. 2003;35:1884–7.CrossRefPubMed
12.
go back to reference Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, Belghiti J, Mantz J. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl. 2009;15:522–9.CrossRefPubMed Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, Belghiti J, Mantz J. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl. 2009;15:522–9.CrossRefPubMed
13.
go back to reference Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr, Pinsky MR. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care. 1993;8:154–60.CrossRefPubMed Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr, Pinsky MR. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care. 1993;8:154–60.CrossRefPubMed
14.
go back to reference Cao Z, Gao Y, Tao G. Vasoplegic syndrome during liver transplantation. Anesth Analg. 2009;108:1941–3.CrossRefPubMed Cao Z, Gao Y, Tao G. Vasoplegic syndrome during liver transplantation. Anesth Analg. 2009;108:1941–3.CrossRefPubMed
15.
go back to reference Fischer GW, Bengtsson Y, Scarola S, Cohen E. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation. J Cardiothorac Vasc Anesth. 2010;24:463–6.CrossRefPubMed Fischer GW, Bengtsson Y, Scarola S, Cohen E. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation. J Cardiothorac Vasc Anesth. 2010;24:463–6.CrossRefPubMed
16.
go back to reference Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2:426–30.CrossRefPubMed Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2:426–30.CrossRefPubMed
17.
go back to reference Wray C, Scovotti JC, Tobis J, Niemann CU, Planinsic R, Walia A, Findlay J, Wagener G, Cywinski JB, Markovic D, et al. Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study. Am J Transplant. 2013;13:184–91.CrossRefPubMed Wray C, Scovotti JC, Tobis J, Niemann CU, Planinsic R, Walia A, Findlay J, Wagener G, Cywinski JB, Markovic D, et al. Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study. Am J Transplant. 2013;13:184–91.CrossRefPubMed
18.
go back to reference Ripoll C, Yotti R, Bermejo J, Banares R. The heart in liver transplantation. J Hepatol. 2011;54:810–22.CrossRefPubMed Ripoll C, Yotti R, Bermejo J, Banares R. The heart in liver transplantation. J Hepatol. 2011;54:810–22.CrossRefPubMed
19.
go back to reference Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589–600.CrossRefPubMed Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589–600.CrossRefPubMed
20.
go back to reference Aniskevich S, Chadha RM, Peiris P, et al. Intra‐operative predictors of postoperative Takotsubo syndrome in liver transplant recipients—An exploratory case‐control study. Clin Transplant. 2017;31:e13092. Aniskevich S, Chadha RM, Peiris P, et al. Intra‐operative predictors of postoperative Takotsubo syndrome in liver transplant recipients—An exploratory case‐control study. Clin Transplant. 2017;31:e13092.
21.
go back to reference Virani SS, Khan AN, Mendoza CE, Ferreira AC, de Marchena E. Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J. 2007;34:76–9.PubMedPubMedCentral Virani SS, Khan AN, Mendoza CE, Ferreira AC, de Marchena E. Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J. 2007;34:76–9.PubMedPubMedCentral
22.
go back to reference Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96:563–73.CrossRefPubMed Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96:563–73.CrossRefPubMed
23.
go back to reference Smith NK, Kim S, Hill B, Goldberg A, DeMaria S, Zerillo J. Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) in liver transplantation: a case report and focused review. Semin Cardiothorac Vasc Anesth. 2018;22:180–90.CrossRefPubMed Smith NK, Kim S, Hill B, Goldberg A, DeMaria S, Zerillo J. Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) in liver transplantation: a case report and focused review. Semin Cardiothorac Vasc Anesth. 2018;22:180–90.CrossRefPubMed
24.
25.
go back to reference Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, Fix OK, Kay N, Abecassis MI, Gheorghiade M, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011;58:223–31.CrossRefPubMed Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, Fix OK, Kay N, Abecassis MI, Gheorghiade M, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011;58:223–31.CrossRefPubMed
26.
go back to reference Bilge AK, Altinkaya E, Ozben B, Pekun F, Adalet K, Yavuz S. Early detection of left ventricular dysfunction with strain imaging in thalassemia patients. Clin Cardiol. 2010;33:E29–34.CrossRefPubMed Bilge AK, Altinkaya E, Ozben B, Pekun F, Adalet K, Yavuz S. Early detection of left ventricular dysfunction with strain imaging in thalassemia patients. Clin Cardiol. 2010;33:E29–34.CrossRefPubMed
27.
go back to reference Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, Bertram S, Beckebaum S, Cicinnati V, Paul A. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011;24:425–32.CrossRefPubMed Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, Bertram S, Beckebaum S, Cicinnati V, Paul A. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int. 2011;24:425–32.CrossRefPubMed
28.
go back to reference Wiese S, Mortensen C, Gotze JP, Christensen E, Andersen O, Bendtsen F, Moller S. Cardiac and proinflammatory markers predict prognosis in cirrhosis. Liver Int. 2014;34:e19–30.CrossRefPubMed Wiese S, Mortensen C, Gotze JP, Christensen E, Andersen O, Bendtsen F, Moller S. Cardiac and proinflammatory markers predict prognosis in cirrhosis. Liver Int. 2014;34:e19–30.CrossRefPubMed
29.
30.
go back to reference Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.CrossRefPubMedPubMedCentral Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.CrossRefPubMedPubMedCentral
31.
go back to reference Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta−2-adrenoceptors in cirrhotic patients with severe ascites. Lancet. 1986;1:1409–11.CrossRefPubMed Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta−2-adrenoceptors in cirrhotic patients with severe ascites. Lancet. 1986;1:1409–11.CrossRefPubMed
32.
go back to reference Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology. 1990;12:481–5.CrossRefPubMed Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology. 1990;12:481–5.CrossRefPubMed
33.
go back to reference Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, Lee SS. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005;146:315–23.CrossRefPubMedPubMedCentral Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, Lee SS. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005;146:315–23.CrossRefPubMedPubMedCentral
34.
go back to reference Hennenberg M, Trebicka J, Sauerbruch T, Heller J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut. 2008;57:1300–14.CrossRefPubMed Hennenberg M, Trebicka J, Sauerbruch T, Heller J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut. 2008;57:1300–14.CrossRefPubMed
35.
go back to reference Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;32:865–75.CrossRefPubMed Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;32:865–75.CrossRefPubMed
Metadata
Title
Acute heart failure after Orthotopic liver transplantation: a case series from one center
Authors
Sonal Sharma
Kunal Karamchandani
Ryan Wilson
Sean Baskin
Dmitri Bezinover
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2018
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-018-0560-2

Other articles of this Issue 1/2018

BMC Anesthesiology 1/2018 Go to the issue